Literature DB >> 16718280

Association between glutamic acid decarboxylase genes and anxiety disorders, major depression, and neuroticism.

J M Hettema1, S S An, M C Neale, J Bukszar, E J C G van den Oord, K S Kendler, X Chen.   

Abstract

Abnormalities in the gamma-aminobutyric acid (GABA) neurotransmitter system have been noted in subjects with mood and anxiety disorders. Glutamic acid decarboxylase (GAD) enzymes synthesize GABA from glutamate, and, thus, are reasonable candidate susceptibility genes for these conditions. In this study, we examined the GAD1 and GAD2 genes for their association with genetic risk across a range of internalizing disorders. We used multivariate structural equation modeling to identify common genetic risk factors for major depression, generalized anxiety disorder, panic disorder, agoraphobia, social phobia and neuroticism (N) in a sample of 9270 adult subjects from the population-based Virginia Adult Twin Study of Psychiatric and Substance Use Disorders. One member from each twin pair for whom DNA was available was selected as a case or control based on scoring at the extremes of the genetic factor extracted from the analysis. The resulting sample of 589 cases and 539 controls was entered into a two-stage association study in which candidate loci were screened in stage 1, the positive results of which were tested for replication in stage 2. Several of the six single-nucleotide polymorphisms tested in the GAD1 region demonstrated significant association in both stages, and a combined analysis in all 1128 subjects indicated that they formed a common high-risk haplotype that was significantly over-represented in cases (P=0.003) with effect size OR=1.23. Out of 14 GAD2 markers screened in stage 1, only one met the threshold criteria for follow-up in stage 2. This marker, plus three others that formed significant haplotype combinations in stage 1, did not replicate their association with the phenotype in stage 2. Subject to confirmation in an independent sample, our study suggests that variations in the GAD1 gene may contribute to individual differences in N and impact susceptibility across a range of anxiety disorders and major depression.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16718280     DOI: 10.1038/sj.mp.4001845

Source DB:  PubMed          Journal:  Mol Psychiatry        ISSN: 1359-4184            Impact factor:   15.992


  69 in total

1.  The AVPR1A gene and substance use disorders: association, replication, and functional evidence.

Authors:  Brion S Maher; Vladimir I Vladimirov; Shawn J Latendresse; Dawn L Thiselton; Rebecca McNamee; Moonsu Kang; Tim B Bigdeli; Xiangning Chen; Brien P Riley; John M Hettema; Howard Chilcoat; Christian Heidbreder; Pierandrea Muglia; E Lenn Murrelle; Danielle M Dick; Fazil Aliev; Arpana Agrawal; Howard J Edenberg; John Kramer; John Nurnberger; Jay A Tischfield; Bernie Devlin; Robert E Ferrell; Galina P Kirillova; Ralph E Tarter; Kenneth S Kendler; Michael M Vanyukov
Journal:  Biol Psychiatry       Date:  2011-04-22       Impact factor: 13.382

Review 2.  Candidate genes in panic disorder: meta-analyses of 23 common variants in major anxiogenic pathways.

Authors:  A S Howe; H N Buttenschøn; A Bani-Fatemi; E Maron; T Otowa; A Erhardt; E B Binder; N O Gregersen; O Mors; D P Woldbye; K Domschke; A Reif; J Shlik; S Kõks; Y Kawamura; A Miyashita; R Kuwano; K Tokunaga; H Tanii; J W Smoller; T Sasaki; D Koszycki; V De Luca
Journal:  Mol Psychiatry       Date:  2015-09-22       Impact factor: 15.992

3.  A whole genome association study of neuroticism using DNA pooling.

Authors:  S Shifman; A Bhomra; S Smiley; N R Wray; M R James; N G Martin; J M Hettema; S S An; M C Neale; E J C G van den Oord; K S Kendler; X Chen; D I Boomsma; C M Middeldorp; J J Hottenga; P E Slagboom; J Flint
Journal:  Mol Psychiatry       Date:  2007-07-31       Impact factor: 15.992

4.  Genetic modulation of GABA levels in the anterior cingulate cortex by GAD1 and COMT.

Authors:  Stefano Marenco; Antonina A Savostyanova; Jan Willem van der Veen; Matthew Geramita; Alexa Stern; Alan S Barnett; Bhaskar Kolachana; Eugenia Radulescu; Fengyu Zhang; Joseph H Callicott; Richard E Straub; Jun Shen; Daniel R Weinberger
Journal:  Neuropsychopharmacology       Date:  2010-03-31       Impact factor: 7.853

5.  GAD65 Promoter Polymorphism rs2236418 Modulates Harm Avoidance in Women via Inhibition/Excitation Balance in the Rostral ACC.

Authors:  Lejla Colic; Meng Li; Liliana Ramona Demenescu; Shija Li; Iris Müller; Anni Richter; Gusalija Behnisch; Constanze I Seidenbecher; Oliver Speck; Björn H Schott; Oliver Stork; Martin Walter
Journal:  J Neurosci       Date:  2018-05-03       Impact factor: 6.167

6.  Genetic association between RGS1 and internalizing disorders.

Authors:  John M Hettema; Seon-Sook An; Edwin J C G van den Oord; Michael C Neale; Kenneth S Kendler; Xiangning Chen
Journal:  Psychiatr Genet       Date:  2013-04       Impact factor: 2.458

7.  Validation of candidate anxiety disorder genes using a carbon dioxide challenge task.

Authors:  Jeanne E Savage; Omari McMichael; Eugenia I Gorlin; Jessica R Beadel; Bethany Teachman; Vladimir I Vladimirov; John M Hettema; Roxann Roberson-Nay
Journal:  Biol Psychol       Date:  2015-04-22       Impact factor: 3.251

8.  TMPRSS9 and GRIN2B are associated with neuroticism: a genome-wide association study in a European sample.

Authors:  Nagesh Aragam; Ke-Sheng Wang; James L Anderson; Xuefeng Liu
Journal:  J Mol Neurosci       Date:  2012-12-11       Impact factor: 3.444

Review 9.  Public health significance of neuroticism.

Authors:  Benjamin B Lahey
Journal:  Am Psychol       Date:  2009 May-Jun

10.  Childhood adversities are associated with shorter telomere length at adult age both in individuals with an anxiety disorder and controls.

Authors:  Laura Kananen; Ida Surakka; Sami Pirkola; Jaana Suvisaari; Jouko Lönnqvist; Leena Peltonen; Samuli Ripatti; Iiris Hovatta
Journal:  PLoS One       Date:  2010-05-25       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.